{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:08:23Z","timestamp":1789837703760,"version":"4.0.1"},"reference-count":394,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Accumulating clinical evidence shows that psychedelic therapy, by synergistically combining psychopharmacology and psychological support, offers a promising transdiagnostic treatment strategy for a range of disorders with restricted and\/or maladaptive habitual patterns of emotion, cognition and behavior, notably, depression (MDD), treatment resistant depression (TRD) and addiction disorders, but perhaps also anxiety disorders, obsessive-compulsive disorder (OCD), Post-Traumatic Stress Disorder (PTSD) and eating disorders. Despite the emergent transdiagnostic evidence, the specific clinical dimensions that psychedelics are efficacious for, and associated underlying neurobiological pathways, remain to be well-characterized. To this end, this review focuses on pre-clinical and clinical evidence of the acute and sustained therapeutic potential of psychedelic therapy in the context of a transdiagnostic dimensional systems framework. Focusing on the Research Domain Criteria (RDoC) as a template, we will describe the multimodal mechanisms underlying the transdiagnostic therapeutic effects of psychedelic therapy, traversing molecular, cellular and network levels. These levels will be mapped to the RDoC constructs of negative and positive valence systems, arousal regulation, social processing, cognitive and sensorimotor systems. In summarizing this literature and framing it transdiagnostically, we hope we can assist the field in moving toward a mechanistic understanding of how psychedelics work for patients and eventually toward a precise-personalized psychedelic therapy paradigm.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.800072","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T08:56:54Z","timestamp":1639731414000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective"],"prefix":"10.3389","volume":"12","author":[{"given":"John R.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Gillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Prenderville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Harkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"O'Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamapsychiatry.2020.2171","article-title":"The current status of psychedelics in psychiatry","volume":"78","author":"Nutt","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jamapsychiatry.2020.3672","article-title":"Psychedelics in psychiatry\u2014keeping the renaissance from going off the rails","volume":"78","author":"Yaden","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11845-021-02668-2","article-title":"Psychedelic perceptions: mental health service user attitudes to psilocybin therapy","author":"Corrigan","year":"2021","journal-title":"Ir J Med Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacol (Berl)."},{"key":"B8","unstructured":"COMP360 Psilocybin Therapy in Treatment-Resistant Depression: Phase IIb Results.2021"},{"key":"B9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J Psychopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J Psychopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e659044","DOI":"10.3389\/fpsyt.2021.659044","article-title":"Psilocybin: from serendipity to credibility?","volume":"12","author":"Rucker","year":"2021","journal-title":"Front Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ipm.2019.39","article-title":"The psychedelic renaissance: the next trip for psychiatry?","author":"Kelly","year":"2019","journal-title":"Ir J Psychol Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211008554","article-title":"Psychedelics and health behaviour change","author":"Teixeira","year":"2021","journal-title":"J Psychopharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J Clin Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s40519-020-01000-8","article-title":"Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder","volume":"26","author":"Spriggs","year":"2020","journal-title":"Eating Weight Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s13311-020-00962-y","article-title":"Exploratory controlled study of the migraine-suppressing effects of psilocybin","volume":"18","author":"Schindler","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/0269881121992676","article-title":"Dose-response relationships of psilocybin-induced subjective experiences in humans","volume":"35","author":"Hirschfeld","year":"2021","journal-title":"J Psychopharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron."},{"key":"B22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnins.2010.00036","article-title":"Htr2a gene and 5-HT(2A) receptor expression in the cerebral cortex studied using genetically modified mice","volume":"4","author":"Weber","year":"2010","journal-title":"Front Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuropharm.2011.01.015","article-title":"Serotonergic regulation of neuronal excitability in the prefrontal cortex","volume":"61","author":"Andrade","year":"2011","journal-title":"Neuropharmacology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-Coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e69320","DOI":"10.7554\/eLife.69320","article-title":"Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD","volume":"10","author":"Burt","year":"2021","journal-title":"Elife"},{"key":"B27","article-title":"Psychedelics Flatten the brain's energy landscape: evidence from receptor-informed network control theory","author":"Singleton","year":"2021","journal-title":"bioRxiv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"20140873","DOI":"10.1098\/rsif.2014.0873","article-title":"Homological scaffolds of brain functional networks","volume":"11","author":"Petri","year":"2014","journal-title":"J. R. Soc. Interface."},{"key":"B29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature."},{"key":"B30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/2045125316689030","article-title":"Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies","volume":"7","author":"Dos Santos","year":"2017","journal-title":"Ther Adv Psychopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e00172","DOI":"10.3389\/fphar.2018.00172","article-title":"Unifying theories of psychedelic drug effects","volume":"9","author":"Swanson","year":"2018","journal-title":"Front. Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e35082","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"Elife"},{"key":"B33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat Rev Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/0269881121991569","article-title":"Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: an in vivo electrophysiology study in male mice","volume":"35","author":"Inserra","year":"2021","journal-title":"J Psychopharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol (Oxford, England)."},{"key":"B36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/09540261.2018.1484342","article-title":"Psychedelics and music: neuroscience and therapeutic implications","volume":"30","author":"Barrett","year":"2018","journal-title":"Int Rev Psychiatry."},{"key":"B37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J Psychopharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"472","DOI":"10.31234\/osf.io\/f5dmt","article-title":"Set and setting: a randomized study of different musical genres in supporting psychedelic therapy","volume":"4","author":"Strickland","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13822","DOI":"10.1111\/psyp.13822","article-title":"LSD and ketanserin and their impact on the human autonomic nervous system","volume":"58","author":"Olbrich","year":"2021","journal-title":"Psychophysiology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","article-title":"Psilocybin induces time-dependent changes in global functional connectivity","volume":"88","author":"Preller","year":"2020","journal-title":"Biol Psychiatry"},{"key":"B42","author":"Daws","year":"2021","journal-title":"Nature Portfolio"},{"key":"B43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/biomedicines8020034","article-title":"Rostral anterior cingulate thickness predicts the emotional psilocybin experience","volume":"8","author":"Lewis","year":"2020","journal-title":"Biomedicines"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1177\/0269881111420188","article-title":"Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness","volume":"25","author":"Maclean","year":"2011","journal-title":"J Psychopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e30800","DOI":"10.1371\/journal.pone.0030800","article-title":"Prediction of psilocybin response in healthy volunteers","volume":"7","author":"Studerus","year":"2012","journal-title":"PLoS ONE."},{"key":"B46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fphar.2018.00897","article-title":"Predicting responses to psychedelics: a prospective study","volume":"9","author":"Haijen","year":"2018","journal-title":"Front Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/00952990.2021.1981357","article-title":"Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives","volume":"47","author":"Cox","year":"2021","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B48","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am J Psychiatry."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e00046","DOI":"10.3389\/fncel.2017.00046","article-title":"Six years of research on the national institute of mental health's research domain criteria (RDoC) initiative: a systematic review","volume":"11","author":"Carcone","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1529100617727266","article-title":"Three approaches to understanding and classifying mental disorder: ICD-11, DSM-5, and the National Institute of Mental Health's Research Domain Criteria (RDoC)","volume":"18","author":"Clark","year":"2017","journal-title":"Psychol Sci Public Interest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","volume":"11","author":"Dos Santos","year":"2018","journal-title":"Expert Rev Clin Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/02791072.2020.1769878","article-title":"A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy","volume":"52","author":"Luoma","year":"2020","journal-title":"J Psychoactive Drugs."},{"key":"B53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am J Psychiatry."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1177\/0269881120919957","article-title":"Efficacy of psychedelic treatments on depressive symptoms: a meta-analysis","volume":"34","author":"Romeo","year":"2020","journal-title":"J Psychopharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00213-020-05719-1","article-title":"Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants","volume":"238","author":"Galv\u00e3o-Coelho","year":"2021","journal-title":"Psychopharmacology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.drudis.2009.05.002","article-title":"Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia","volume":"14","author":"Krystal","year":"2009","journal-title":"Drug Discov Today."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1038\/tp.2016.92","article-title":"Cytokine production capacity in depression and anxiety","volume":"6","author":"Vogelzangs","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e203221","DOI":"10.1001\/jamanetworkopen.2020.3221","article-title":"Longitudinal assessment of mental health disorders and comorbidities across 4 decades among participants in the dunedin birth cohort study","volume":"3","author":"Caspi","year":"2020","journal-title":"JAMA Network Open."},{"key":"B59","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.bpsc.2020.04.013","article-title":"Carving out new transdiagnostic dimensions for research in mental health","volume":"5","author":"Gillan","year":"2020","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"B60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamapsychiatry.2019.3351","article-title":"Shared neural phenotypes for mood and anxiety disorders: a meta-analysis of 226 task-related functional imaging studies","volume":"77","author":"Janiri","year":"2020","journal-title":"JAMA Psychiatry."},{"key":"B61","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1176\/appi.ajp.2017.16040400","article-title":"Identification of common neural circuit disruptions in cognitive control across psychiatric disorders","volume":"174","author":"McTeague","year":"2017","journal-title":"Am J Psychiatry."},{"key":"B62","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.biopsych.2018.11.011","article-title":"Common dysfunction of large-scale neurocognitive networks across psychiatric disorders","volume":"85","author":"Sha","year":"2019","journal-title":"Biol Psychiatry."},{"key":"B63","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1176\/appi.ajp.2020.19030331","article-title":"Subcortical brain volume, regional cortical thickness, and cortical surface area across disorders: findings from the ENIGMA ADHD. ASD, and OCD Working Groups","volume":"177","author":"Boedhoe","year":"2020","journal-title":"Am J Psychiatry"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0140-6736(12)62129-1","article-title":"Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis","volume":"381","author":"Smoller","year":"2013","journal-title":"Lancet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"eaap8757","DOI":"10.1126\/science.aap8757","article-title":"Analysis of shared heritability in common disorders of the brain","volume":"360","author":"Brainstorm","year":"2018","journal-title":"Science (New York, N.Y.)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.12.426438","article-title":"Decoding shared versus divergent transcriptomic signatures across cortico-amygdala circuitry in PTSD and depressive disorders","author":"Jaffe","year":"2021","journal-title":"bioRxiv."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.21.257758","article-title":"Towards reproducible brain-wide association studies","author":"Marek","year":"2020","journal-title":"bioRxiv"},{"key":"B68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jamapediatrics.2020.5602","article-title":"Population vs. individual prediction of poor health from results of adverse childhood experiences screening","volume":"175","author":"Baldwin","year":"2021","journal-title":"JAMA Pediatr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cobeha.2017.07.003","article-title":"What big data can do for treatment in psychiatry","volume":"18","author":"Gillan","year":"2017","journal-title":"Curr Opin Behav Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41591-020-0806-7","article-title":"A randomized proof-of-mechanism trial applying the \u2018fast-fail' approach to evaluating \u03ba-opioid antagonism as a treatment for anhedonia","volume":"26","author":"Krystal","year":"2020","journal-title":"Nat Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/da.23006","article-title":"Positive and negative valence systems in major depression have distinct clinical features, response to antidepressants, and relationships with immunomarkers","volume":"37","author":"Medeiros","year":"2020","journal-title":"Depress Anxiety."},{"key":"B72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpsychires.2016.03.001","article-title":"Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): rationale and design","volume":"78","author":"Trivedi","year":"2016","journal-title":"J Psychiatr Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2398212818804030","DOI":"10.1177\/2398212818804030","article-title":"The research domain criteria framework in drug discovery for neuropsychiatric diseases: focus on negative valence","volume":"2","author":"Nicholson","year":"2018","journal-title":"Brain Neurosci Adv."},{"key":"B74","unstructured":"Research Domain Criteria.2021"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.copsyc.2015.01.004","article-title":"Integrating NIMH research domain criteria (RDoC) into depression research","volume":"4","author":"Woody","year":"2015","journal-title":"Curr Opin Psychol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1177\/0269881116679368","article-title":"Psychedelics in the treatment of unipolar mood disorders: a systematic review","volume":"30","author":"Rucker","year":"2016","journal-title":"J Psychopharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: a systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"J Affect Disord."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1017\/S003329172000389X","article-title":"Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis","volume":"50","author":"Goldberg","year":"2020","journal-title":"Psychol Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.13249","article-title":"Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies","volume":"143","author":"Andersen","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"B80","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancerpsilocybin for anxiety in advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"JAMA Psychiatry."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol (Oxford, England)."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J Psychopharmacol (Oxford, England)."},{"key":"B83","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl Psychiatry."},{"key":"B84","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology."},{"key":"B85","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: CHANGES in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J Psychopharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00213-017-4754-y","article-title":"Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression","volume":"235","author":"Stroud","year":"2018","journal-title":"Psychopharmacology (Berl)."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e00974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0022167817709585","article-title":"Patients' accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J Human Psychol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fpsyg.2019.01234","article-title":"Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: observation from a randomized controlled trial","volume":"10","author":"De Almeida","year":"2019","journal-title":"Front Psychol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3389\/fphar.2019.01325","article-title":"The impact of ayahuasca on suicidality: results from a randomized controlled trial","volume":"10","author":"Zeifman","year":"2019","journal-title":"Front Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fpsyt.2018.00185","article-title":"Cortisol modulation by ayahuasca in patients with treatment resistant depression and healthy controls","volume":"9","author":"Galv\u00e3o","year":"2018","journal-title":"Front Psychiatry."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1177\/0269881120936486","article-title":"Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca","volume":"34","author":"Galv\u00e3o-Coelho","year":"2020","journal-title":"J Psychopharmacol (Oxford, England)."},{"key":"B94","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"J Clin Psychopharmacol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00213-020-05692-9","article-title":"Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial","volume":"238","author":"Zeifman","year":"2021","journal-title":"Psychopharmacology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","volume":"37","author":"Os\u00f3rio","year":"2015","journal-title":"Braz J Psychiatry."},{"key":"B97","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J Psychopharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer","volume":"4","author":"Ross","year":"2021","journal-title":"ACS Pharmacol Transl Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser","year":"2015","journal-title":"J Psychopharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J Nerv Ment Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/ipm.2020.94","article-title":"Psychedelic science in post-COVID-19 psychiatry","volume":"38","author":"Kelly","year":"2021","journal-title":"Ir J Psychol Med."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2487","article-title":"Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, cross-over study in healthy subjects","author":"Becker","year":"2021","journal-title":"Clin Pharmacol Therap"},{"key":"B104","doi-asserted-by":"publisher","first-page":"102781","DOI":"10.1016\/j.nicl.2021.102781","article-title":"Amygdala substructure volumes in major depressive disorder","volume":"31","author":"Roddy","year":"2021","journal-title":"NeuroImage Clin."},{"key":"B105","doi-asserted-by":"publisher","first-page":"100062","DOI":"10.1016\/j.ynirp.2021.100062","article-title":"The human dorsal hippocampal commissure: Delineating connections across the midline using multi-modal neuroimaging in major depressive disorder","volume":"1","author":"Nasa","year":"2021","journal-title":"Neuroimage Rep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","article-title":"Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD social anxiety disorder, specific phobia","volume":"164","author":"Etkin","year":"2007","journal-title":"Am J Psychiatry."},{"key":"B107","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neubiorev.2012.11.015","article-title":"Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies","volume":"37","author":"Groenewold","year":"2013","journal-title":"Neurosci Biobehav Rev."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/npp.2013.69","article-title":"Munaf\u00f2 MR, Nutt DJ, Robinson ES. A translational rodent assay of affective biases in depression and antidepressant therapy","volume":"38","author":"Stuart","year":"2013","journal-title":"Neuropsychopharmacology."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2021.09.001","article-title":"Neural responsivity to reward versus punishment shortly after trauma predicts long-term development of post-traumatic stress symptoms","author":"Ben-Zion","year":"2021","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"B110","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biol Psychiatry."},{"key":"B111","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol Psychiatry."},{"key":"B112","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euroneuro.2018.03.016","article-title":"Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination","volume":"28","author":"Grimm","year":"2018","journal-title":"Eur Neuropsychopharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1038\/npp.2016.82","article-title":"LSD acutely impairs fear recognition and enhances emotional empathy and sociality","volume":"41","author":"Dolder","year":"2016","journal-title":"Neuropsychopharmacology."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e1084","DOI":"10.1038\/tp.2017.54","article-title":"Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects","volume":"7","author":"Mueller","year":"2017","journal-title":"Transl Psychiatry."},{"key":"B116","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bpsc.2019.12.007","volume":"5","author":"Bershad","year":"2020","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging."},{"key":"B117","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/JCP.0000000000001396","article-title":"Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial","volume":"41","author":"Rocha","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1745-6924.2008.00088.x","article-title":"Rethinking rumination","volume":"3","author":"Nolen-Hoeksema","year":"2008","journal-title":"Perspect Psychol Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3758\/CABN.10.4.470","article-title":"Neural correlates of rumination in depression","volume":"10","author":"Cooney","year":"2010","journal-title":"Cogn Affect Behav Neurosci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsych.2015.02.020","article-title":"Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience","volume":"78","author":"Hamilton","year":"2015","journal-title":"Biol Psychiatry."},{"key":"B121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1590\/1516-4446-2018-0140","article-title":"Acute effects of ayahuasca in a juvenile non-human primate model of depression","volume":"41","author":"Da Silva","year":"2019","journal-title":"Braz J Psychiatry."},{"key":"B122","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00213-019-05414-w","article-title":"Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment","volume":"237","author":"Uthaug","year":"2020","journal-title":"Psychopharmacology."},{"key":"B123","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamapsychiatry.2017.0270","article-title":"Allostasis and the epigenetics of brain and body health over the life course: the brain on stress","volume":"74","author":"Mcewen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B124","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.11.036","article-title":"Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis","volume":"77","author":"Zorn","year":"2017","journal-title":"Psychoneuroendocrinology."},{"key":"B125","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp Brain Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem Neurosci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic NN-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem Neurosci."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.24.432725","article-title":"Prolonged epigenetic and synaptic plasticity alterations following single exposure to a psychedelic in mice","author":"De La Fuente Revenga","year":"2021","journal-title":"bioRxiv"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e687615","DOI":"10.3389\/fpsyt.2021.687615","article-title":"Ceremonial ayahuasca in amazonian retreats\u2014mental health and epigenetic outcomes from a six-month naturalistic study","volume":"12","author":"Ruffell","year":"2021","journal-title":"Front Psychiatry."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.12.248229","article-title":"Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release","author":"Jones","year":"2020","journal-title":"bioRxiv"},{"key":"B131","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1017\/neu.2019.15","article-title":"Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat","volume":"31","author":"Jefsen","year":"2019","journal-title":"Acta Neuropsychiatr."},{"key":"B132","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem Neurosci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/da.23065","article-title":"Historic psychedelic drug trials and the treatment of anxiety disorders","volume":"37","author":"Weston","year":"2020","journal-title":"Depress Anxiety"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.09.012","article-title":"Maji\u0107 T. Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: a systematic review","volume":"81","author":"Reiche","year":"2018","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.jpsychires.2013.05.031","article-title":"Disrupted amygdala-prefrontal functional connectivity in civilian women with posttraumatic stress disorder","volume":"47","author":"Stevens","year":"2013","journal-title":"J Psychiatr Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/npp.2013.197","article-title":"Altered resting-state functional connectivity of basolateral and centromedial amygdala complexes in posttraumatic stress disorder","volume":"39","author":"Brown","year":"2014","journal-title":"Neuropsychopharmacology."},{"key":"B137","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamapsychiatry.2016.3325","article-title":"An integrated neuroscience perspective on formulation and treatment planning for posttraumatic stress disorder: an educational review","volume":"74","author":"Ross","year":"2017","journal-title":"JAMA Psychiatry."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.biopsych.2016.11.015","article-title":"Amygdala reactivity and anterior cingulate habituation predict posttraumatic stress disorder symptom maintenance after acute civilian trauma","volume":"81","author":"Stevens","year":"2017","journal-title":"Biol Psychiatry."},{"key":"B139","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.biopsych.2020.11.021","article-title":"Amygdala and insula connectivity changes following psychotherapy for posttraumatic stress disorder: a randomized clinical trial","volume":"89","author":"Fonzo","year":"2021","journal-title":"Biol Psychiatry."},{"key":"B140","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2006.07.029","article-title":"Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala","volume":"51","author":"Etkin","year":"2006","journal-title":"Neuron."},{"key":"B141","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.biopsych.2017.10.004","article-title":"Face perception in social anxiety: visuocortical dynamics reveal propensities for hypervigilance or avoidance","volume":"83","author":"Mcteague","year":"2018","journal-title":"Biol Psychiatry."},{"key":"B142","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00213-020-05756-w","article-title":"The acute effects of classic psychedelics on memory in humans","volume":"238","author":"Healy","year":"2021","journal-title":"Psychopharmacology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00213-017-4820-5","article-title":"The hidden therapist: evidence for a central role of music inpsychedelic therapy","volume":"235","author":"Kaelen","year":"2018","journal-title":"Psychopharmacology."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.euroneuro.2016.03.018","article-title":"LSD modulates music-induced imagery via changes in parahippocampal connectivity","volume":"26","author":"Kaelen","year":"2016","journal-title":"Eur Neuropsychopharmacol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","article-title":"Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin","volume":"200","author":"Carhart-Harris","year":"2012","journal-title":"Br J Psychiatry."},{"key":"B146","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.conb.2015.07.009","article-title":"Memory engram storage and retrieval","volume":"35","author":"Tonegawa","year":"2015","journal-title":"Curr Opin Neurobiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.conb.2021.01.006","article-title":"Engram cell connectivity: an evolving substrate for information storage","volume":"67","author":"Ryan","year":"2021","journal-title":"Curr Opin Neurobiol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2470547020939564","DOI":"10.1177\/2470547020939564","article-title":"Psychedelic treatment for trauma-related psychological and cognitive impairment among us special operations forces veterans","volume":"4","author":"Davis","year":"2020","journal-title":"Chronic Stress."},{"key":"B149","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int J Neuropsychopharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","article-title":"Psychedelic psychiatry's brave new world","volume":"181","author":"Nutt","year":"2020","journal-title":"Cell."},{"key":"B151","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fpsyt.2020.00005","article-title":"Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance","volume":"11","author":"Wolff","year":"2020","journal-title":"Front Psychiatry."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e00782","DOI":"10.3389\/fpsyt.2020.00782","article-title":"Post-psychedelic reductions in experiential avoidance are associated with decreases in depression severity and suicidal ideation","volume":"11","author":"Zeifman","year":"2020","journal-title":"Front Psychiatry."},{"key":"B153","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/acsptsci.0c00169","article-title":"Psilocybin-assisted group therapy and attachment: observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience","volume":"4","author":"Stauffer","year":"2021","journal-title":"ACS Pharmacol Transl Sci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/0269881121998322","article-title":"Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies","volume":"35","author":"Studerus","year":"2021","journal-title":"J Psychopharmacol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/sj.npp.1301283","article-title":"Amygdala-prefrontal disconnection in borderline personality disorder","volume":"32","author":"New","year":"2007","journal-title":"Neuropsychopharmacology."},{"key":"B156","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pscychresns.2016.12.009","article-title":"Impulsivity and aggression mediate regional brain responses in Borderline Personality Disorder: an fMRI study","volume":"260","author":"Soloff","year":"2017","journal-title":"Psychiatry Res Neuroimaging."},{"key":"B157","doi-asserted-by":"publisher","first-page":"102025","DOI":"10.1016\/j.cpr.2021.102025","article-title":"Linking RDoC and HiTOP: A new interface for advancing psychiatric nosology and neuroscience","volume":"86","author":"Michelini","year":"2021","journal-title":"Clin Psychol Rev"},{"key":"B158","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jad.2019.09.021","article-title":"Response to ostracism in patients with chronic depression, episodic depression and borderline personality disorder a study using Cyberball","volume":"260","author":"Seidl","year":"2020","journal-title":"J Affect Disord."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcbs.2019.11.001","article-title":"Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder","volume":"15","author":"Zeifman","year":"2020","journal-title":"J Context Behav Sci."},{"key":"B160","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00213-018-5085-3","article-title":"Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits","volume":"236","author":"Dom\u00ednguez-Clav\u00e9","year":"2019","journal-title":"Psychopharmacology (Berl)."},{"key":"B161","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s00213-020-05568-y","article-title":"Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism","volume":"237","author":"Van Mulukom","year":"2020","journal-title":"Psychopharmacology (Berl)."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1017\/S0033291715002901","article-title":"The paradoxical psychological effects of lysergic acid diethylamide (LSD)","volume":"46","author":"Carhart-Harris","year":"2016","journal-title":"Psychol Med."},{"key":"B163","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neubiorev.2018.02.004","article-title":"Serotonergic psychedelics and personality: a systematic review of contemporary research","volume":"87","author":"Bouso","year":"2018","journal-title":"Neurosci Biobehav Rev."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1177\/0269881119827891","article-title":"Recreational use of psychedelics is associated with elevated personality trait openness: exploration of associations with brain serotonin markers","volume":"33","author":"Erritzoe","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1002\/hbm.23234","article-title":"LSD-induced entropic brain activity predicts subsequent personality change","volume":"37","author":"Lebedev","year":"2016","journal-title":"Hum Brain Mapp."},{"key":"B166","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/hbm.24511","article-title":"Trait OPENNESS and serotonin 2A receptors in healthy volunteers: a positron emission tomography study","volume":"40","author":"Stenbaek","year":"2019","journal-title":"Hum Brain Mapp."},{"key":"B167","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","volume":"33","author":"Madsen","year":"2020","journal-title":"Eur Neuropsychopharmacol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J Neurosci"},{"key":"B169","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1038\/s41598-017-05407-9","article-title":"The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro","volume":"7","author":"Morales-Garcia","year":"2017","journal-title":"Sci Rep."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1179069518800508","DOI":"10.1177\/1179069518800508","article-title":"Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics","volume":"12","author":"Olson","year":"2018","journal-title":"J Exp Neurosci"},{"key":"B171","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3389\/fpsyt.2021.724606","article-title":"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"De Vos","year":"2021","journal-title":"Front Psychiatry."},{"key":"B173","doi-asserted-by":"publisher","first-page":"727117","DOI":"10.3389\/fpsyt.2021.727117","article-title":"Psychedelics and other psychoplastogens for treating mental illness","volume":"12","author":"Vargas","year":"2021","journal-title":"Front Psychiatry"},{"key":"B174","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B175","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ijnp\/pyaa087","article-title":"Ketamine and serotonergic psychedelics: common mechanisms underlying the effects of rapid-acting antidepressants","volume":"24","author":"Kadriu","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology."},{"key":"B177","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"B178","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1021\/acsptsci.0c00065","article-title":"Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth","volume":"4","author":"Ly","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B179","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"B180","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/ijms22020835","article-title":"A single dose of psilocybin increases synaptic density and decreases 5-HT(2A) receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B181","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0893-133X(01)00405-5","article-title":"A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain","volume":"26","author":"Nichols","year":"2002","journal-title":"Neuropsychopharmacology."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.03.013","article-title":"Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia","volume":"83","author":"Martin","year":"2014","journal-title":"Neuropharmacology."},{"key":"B183","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0269881120959614","article-title":"Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin","volume":"35","author":"Jefsen","year":"2021","journal-title":"J Psychopharmacol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature."},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01159-1","article-title":"An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress","author":"Lu","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B186","doi-asserted-by":"publisher","first-page":"eaat8078","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"B187","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"B188","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B189","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology."},{"key":"B190","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1866-1955-4-19","article-title":"Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings","volume":"4","author":"Dichter","year":"2012","journal-title":"J Neurodev Disord."},{"key":"B191","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00213-014-3662-7","article-title":"Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders","volume":"232","author":"H\u00e4gele","year":"2015","journal-title":"Psychopharmacology."},{"key":"B192","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jad.2017.02.001","article-title":"Reward processing and mood-related symptoms: an RDoC and translational neuroscience perspective","volume":"216","author":"Nusslock","year":"2017","journal-title":"J Affect Disord."},{"key":"B193","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.biopsych.2020.11.017","article-title":"Trauma affects prospective relationships between reward-related ventral striatal and amygdala activation and 1-year future hypo\/mania trajectories","volume":"89","author":"Eckstrand","year":"2021","journal-title":"Biol Psychiatry."},{"key":"B194","doi-asserted-by":"publisher","first-page":"e00439","DOI":"10.3389\/fnbeh.2014.00439","article-title":"Neural sensitivity to social reward and punishment anticipation in social anxiety disorder","volume":"8","author":"Cremers","year":"","journal-title":"Front Behav Neurosci"},{"key":"B195","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fnins.2020.00154","article-title":"Reward circuitry and motivational deficits in social anxiety disorder: what can be learned from mouse models?","volume":"14","author":"Carlton","year":"2020","journal-title":"Front Neurosci."},{"key":"B196","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijpsycho.2015.01.011","article-title":"Abnormal reward functioning across substance use disorders and major depressive disorder: considering reward as a transdiagnostic mechanism","volume":"98","author":"Baskin-Sommers","year":"2015","journal-title":"Int J Psychophysiol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol Rev."},{"key":"B198","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fnbeh.2014.00395","article-title":"Frontostriatal circuits and the development of bulimia nervosa","volume":"8","author":"Berner","year":"2014","journal-title":"Front Behav Neurosci."},{"key":"B199","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40337-016-0106-2","article-title":"Neurobiological model of the persistence of anorexia nervosa","volume":"4","author":"Steinglass","year":"2016","journal-title":"J Eat Disord."},{"key":"B200","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00213-005-2183-9","article-title":"Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis","volume":"180","author":"Marona-Lewicka","year":"2005","journal-title":"Psychopharmacology (Berl)."},{"key":"B201","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.phrs.2016.08.022","article-title":"The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors","volume":"113","author":"De Gregorio","year":"2016","journal-title":"Pharmacol Res."},{"key":"B202","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1248\/bpb.b14-00315","article-title":"Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats","volume":"38","author":"Sakashita","year":"2015","journal-title":"Biol Pharm Bull."},{"key":"B203","doi-asserted-by":"publisher","first-page":"e2022489118","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc Nat Acad Sci."},{"key":"B204","doi-asserted-by":"publisher","first-page":"117456","DOI":"10.1016\/j.neuroimage.2020.117456","article-title":"Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice","volume":"225","author":"Grandjean","year":"2021","journal-title":"Neuroimage."},{"key":"B205","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc Nat Acad Sci."},{"key":"B206","doi-asserted-by":"publisher","first-page":"e0118143","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS ONE."},{"key":"B207","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc Nat Acad Sci."},{"key":"B208","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"Neuroimage."},{"key":"B209","doi-asserted-by":"publisher","first-page":"14914","DOI":"10.1038\/s41598-019-50612-3","article-title":"Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat","volume":"9","author":"Smigielski","year":"2019","journal-title":"Sci Rep."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","volume":"25","author":"Studerus","year":"2011","journal-title":"J Psychopharmacol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","article-title":"5-HT Modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man\u2014A PET study with [11C]raclopride","volume":"20","author":"Vollenweider","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"B212","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport."},{"key":"B213","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.pbr.2017.08.002","article-title":"Using the research domain criteria (RDoC) to conceptualize impulsivity and compulsivity in relation to addiction","volume":"235","author":"Brooks","year":"2017","journal-title":"Prog Brain Res."},{"key":"B214","doi-asserted-by":"publisher","first-page":"e63972","DOI":"10.1371\/journal.pone.0063972","article-title":"Johansen P-\u00d8. Psychedelics and mental health: a population study","volume":"8","author":"Krebs","year":"2013","journal-title":"PLOS ONE."},{"key":"B215","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The abuse potential of medical psilocybin according to the 8 factors of the controlled substances act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology."},{"key":"B216","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J Psychopharmacol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1007\/s11033-020-06009-x","article-title":"Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review","volume":"47","author":"Divito","year":"2020","journal-title":"Mol Biol Rep."},{"key":"B218","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fphar.2018.00132","article-title":"The psychedelic debriefing in alcohol dependence treatment: illustrating key change phenomena through qualitative content analysis of clinical sessions","volume":"9","author":"Nielson","year":"2018","journal-title":"Front Pharmacol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881119845793","article-title":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","volume":"33","author":"Garcia-Romeu","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s41386-020-0694-z","article-title":"Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse","volume":"45","author":"Meinhardt","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"B221","doi-asserted-by":"publisher","first-page":"eabh2399","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci Adv"},{"key":"B222","doi-asserted-by":"publisher","first-page":"e640241","DOI":"10.3389\/fphar.2021.640241","article-title":"Low doses of psilocybin and ketamine enhance motivation and attention in poor performing rats: evidence for an antidepressant property","volume":"12","author":"Higgins","year":"2021","journal-title":"Front. Pharmacol"},{"key":"B223","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2014","journal-title":"Curr Drug Abuse Rev."},{"key":"B224","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1177\/0269881118780612","article-title":"Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts","volume":"32","author":"Noorani","year":"2018","journal-title":"J Psychopharmacol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijpsycho.2015.06.004","article-title":"Asymmetrical frontal cortical activity associated with differential risk for mood and anxiety disorder symptoms: an RDoC perspective","volume":"98","author":"Nusslock","year":"2015","journal-title":"Int J Psychophysiol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/02791072.2017.1344898","article-title":"Cornelius C. A physician's attempt to self-medicate bipolar depression with NN-dimethyltryptamine (DMT)","volume":"49","author":"Brown","year":"2017","journal-title":"J Psychoactive Drugs."},{"key":"B227","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40345-014-0020-y","article-title":"Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report","volume":"3","author":"Szmulewicz","year":"2015","journal-title":"Int J Bipolar Disord."},{"key":"B228","doi-asserted-by":"publisher","first-page":"100240","DOI":"10.1016\/j.jadr.2021.100240","article-title":"Evaluating the risk of psilocybin for the treatment of bipolar depression: a review of the research literature and published case studies","volume":"6","author":"Gard","year":"2021","journal-title":"J Affect Disord Rep"},{"key":"B229","volume-title":"Realms of the Human Unconscious Observations From LSD Research","author":"Grof","year":"1975"},{"key":"B230","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00213-014-3714-z","article-title":"enhances suggestibility in healthy volunteers","volume":"232","author":"Carhart-Harris","year":"2015","journal-title":"Psychopharmacology (Berl)."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J Psychopharmacol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2018.00177","article-title":"Neuroendocrine associations underlying the persistent therapeutic effects of classic serotonergic psychedelics","volume":"9","author":"Schindler","year":"2018","journal-title":"Front Pharmacol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"e00358","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and Immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front Immunol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol Psychiatry."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40262-017-0513-9","article-title":"Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects","volume":"56","author":"Dolder","year":"2017","journal-title":"Clin Pharmacokinet."},{"key":"B236","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD. MDMA, and d-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"B237","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","article-title":"Qualls CR. Dose-response study of NN-dimethyltryptamine in humans I Neuroendocrine, autonomic, cardiovascular effects","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch Gen Psychiatry."},{"key":"B238","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/0006-3223(95)00200-6","article-title":"Differential tolerance to biological and subjective effects of four closely spaced doses of NN-dimethyltryptamine in humans","volume":"39","author":"Strassman","year":"1996","journal-title":"Biol Psychiatry."},{"key":"B239","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology (Berl)."},{"key":"B240","doi-asserted-by":"publisher","first-page":"12374","DOI":"10.1111\/jne.12374","article-title":"Acute effects of lysergic acid diethylamide on circulating steroid levels in healthy subjects","volume":"28","author":"Strajhar","year":"2016","journal-title":"J Neuroendocrinol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency","volume":"327","author":"Yu","year":"2008","journal-title":"J Pharmacol Exp Ther."},{"key":"B242","doi-asserted-by":"publisher","first-page":"e75426","DOI":"10.1371\/journal.pone.0075426","article-title":"Serotonin 5-HT2A receptor activation blocks TNF-\u03b1 mediated inflammation in vivo","volume":"8","author":"Nau","year":"2013","journal-title":"PLoS ONE"},{"key":"B243","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/02791072.2014.960113","article-title":"Immunological effects of ayahuasca in humans","volume":"46","author":"Dos Santos","year":"2014","journal-title":"J Psychoactive Drugs."},{"key":"B244","doi-asserted-by":"publisher","first-page":"e106533","DOI":"10.1371\/journal.pone.0106533","article-title":"Psychedelic NN-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells","volume":"9","author":"Szabo","year":"2014","journal-title":"PLoS ONE."},{"key":"B245","doi-asserted-by":"publisher","first-page":"e00423","DOI":"10.3389\/fnins.2016.00423","article-title":"The endogenous hallucinogen and trace amine N.N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells","volume":"10","author":"Szabo","year":"2016","journal-title":"Front. Neurosci"},{"key":"B246","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int Rev Psychiatry."},{"key":"B247","doi-asserted-by":"publisher","first-page":"116790","DOI":"10.1016\/j.lfs.2019.116790","article-title":"5-HT2 receptor activation alleviates airway inflammation and structural remodeling in a chronic mouse asthma model","volume":"236","author":"Flanagan","year":"2019","journal-title":"Life Sci"},{"key":"B248","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1038\/s41598-019-49987-0","article-title":"Activation of 5-HT(2) Receptors reduces inflammation in vascular tissue and cholesterol levels in high-fat diet-fed apolipoprotein e knockout mice","volume":"9","author":"Flanagan","year":"2019","journal-title":"Sci Rep."},{"key":"B249","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s11481-013-9462-8","article-title":"Evidence for a dysregulated immune system in the etiology of psychiatric disorders","volume":"8","author":"Gibney","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1038\/tp.2013.27","article-title":"Anxiety disorders and inflammation in a large adult cohort","volume":"3","author":"Vogelzangs","year":"2013","journal-title":"Transl Psychiatry."},{"key":"B251","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol Med."},{"key":"B252","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.imlet.2020.10.001","article-title":"Psychedelics as a novel approach to treating autoimmune conditions","volume":"228","author":"Thompson","year":"2020","journal-title":"Immunol Lett."},{"key":"B253","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/rapm-2020-101273","article-title":"Chronic pain and psychedelics: a review and proposed mechanism of action. Regional Anesthesia andamp","volume":"45","author":"Castellanos","year":"2020","journal-title":"Pain Med"},{"key":"B254","doi-asserted-by":"publisher","first-page":"735427","DOI":"10.3389\/fpsyt.2021.735427","article-title":"Self-medication for chronic pain using classic psychedelics: a qualitative investigation to inform future research","volume":"12","author":"Bornemann","year":"2021","journal-title":"Front Psychiatry"},{"key":"B255","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S2215-0366(20)30136-X","article-title":"Sleep disturbance and psychiatric disorders","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiatry."},{"key":"B256","doi-asserted-by":"publisher","first-page":"e602590","DOI":"10.3389\/fphar.2020.602590","article-title":"The effects of daytime psilocybin administration on sleep: implications for antidepressant action","volume":"11","author":"Dudysov\u00e1","year":"2020","journal-title":"Front Pharmacol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.tics.2011.11.013","article-title":"The social brain meets neuroimaging","volume":"16","author":"Dunbar","year":"2012","journal-title":"Trends Cogn Sci."},{"key":"B258","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.aam6383","article-title":"A dedicated network for social interaction processing in the primate brain","volume":"356","author":"Sliwa","year":"2017","journal-title":"Science."},{"key":"B259","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41593-020-00742-z","article-title":"Acute social isolation evokes midbrain craving responses similar to hunger","volume":"23","author":"Tomova","year":"2020","journal-title":"Nat Neurosci."},{"key":"B260","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/S2468-2667(19)30230-0","article-title":"Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): a longitudinal mediation analysis","volume":"5","author":"Santini","year":"2020","journal-title":"Lancet Public Health."},{"key":"B261","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology."},{"key":"B262","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1523\/JNEUROSCI.1939-17.2018","article-title":"Role of the 5-HT2A receptor in self- and other-initiated social interaction in lysergic acid diethylamide-induced states: a pharmacological fMRI study","volume":"38","author":"Preller","year":"2018","journal-title":"J Neurosci."},{"key":"B263","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1038\/s41598-020-68899-y","article-title":"LSD-induced increases in social adaptation to opinions similar to one's own are associated with stimulation of serotonin receptors","volume":"10","author":"Duerler","year":"2020","journal-title":"Sci Rep."},{"key":"B264","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","article-title":"Assessing the psychedelic \u201cafter-glow\u201d in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities","volume":"20","author":"Sampedro","year":"2017","journal-title":"Int J Neuropsychopharmacol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/hbm.22833","article-title":"Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin","volume":"36","author":"Lebedev","year":"2015","journal-title":"Hum Brain Mapp."},{"key":"B266","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J Psychopharmacol."},{"key":"B267","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1073\/pnas.1524187113","article-title":"Effects of serotonin 2A\/1A receptor stimulation on social exclusion processing","volume":"113","author":"Preller","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B268","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","article-title":"Effect of psilocybin on empathy and moral decision-making","volume":"20","author":"Pokorny","year":"2017","journal-title":"Int J Neuropsychopharmacol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"e2020705118","DOI":"10.1073\/pnas.2020705118","article-title":"Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission","volume":"118","author":"De Gregorio","year":"2021","journal-title":"Proc Nat Acad Sci."},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.09.289348","article-title":"Psilocybin rescues sociability deficits in an animal model of autism","author":"Mollinedo-Gajate","year":"2020","journal-title":"bioRxiv"},{"key":"B271","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-017-4701-y","article-title":"Psychedelics and connectedness","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl)."},{"key":"B272","doi-asserted-by":"publisher","first-page":"e623985","DOI":"10.3389\/fphar.2021.623985","article-title":"Psychedelic communitas: intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social connectedness","volume":"12","author":"Kettner","year":"2021","journal-title":"Front Pharmacol"},{"key":"B273","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/0269881117748902","article-title":"Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression","volume":"32","author":"Lyons","year":"2018","journal-title":"J Psychopharmacol."},{"key":"B274","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.3390\/ijerph16245147","article-title":"From egoism to ecoism: psychedelics increase nature relatedness in a state-mediated and context-dependent manner","volume":"16","author":"Kettner","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"B275","doi-asserted-by":"publisher","first-page":"2055102920978123","DOI":"10.1177\/2055102920978123","article-title":"The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health","volume":"7","author":"Gandy","year":"2020","journal-title":"Health Psychology Open."},{"key":"B276","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1177\/0269881117714049","article-title":"Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness","volume":"31","author":"Forstmann","year":"2017","journal-title":"J Psychopharmacol."},{"key":"B277","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"B278","doi-asserted-by":"publisher","first-page":"e607529","DOI":"10.3389\/fphar.2021.607529","article-title":"Relational processes in ayahuasca groups of palestinians and israelis","volume":"12","author":"Roseman","year":"2021","journal-title":"Front Pharmacol"},{"key":"B279","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","article-title":"Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies","volume":"34","author":"Breeksema","year":"2020","journal-title":"CNS Drugs."},{"key":"B280","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S2215-0366(16)00045-6","article-title":"The fragmented self: imbalance between intrinsic and extrinsic self-networks in psychotic disorders","volume":"3","author":"Ebisch","year":"2016","journal-title":"Lancet Psychiatry."},{"key":"B281","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am J Psychiatry."},{"key":"B282","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.2174\/1568026616666160608084834","article-title":"Dopamine targeting drugs for the treatment of schizophrenia: past, present and future","volume":"16","author":"Li","year":"2016","journal-title":"Curr Top Med Chem."},{"key":"B283","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0269881120959609","article-title":"Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans","volume":"35","author":"Stenb\u00e6k","year":"2020","journal-title":"J Psychopharmacol."},{"key":"B284","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1440.011","article-title":"The brain's default network: anatomy, function, and relevance to disease","volume":"1124","author":"Buckner","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B285","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/awq010","article-title":"The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas","volume":"133","author":"Carhart-Harris","year":"2010","journal-title":"Brain."},{"key":"B286","doi-asserted-by":"publisher","first-page":"e579703","DOI":"10.3389\/fnhum.2020.579703","article-title":"Intrinsic connectivity networks in the self- and other-referential processing","volume":"14","author":"Knyazev","year":"2020","journal-title":"Front Human Neurosci"},{"key":"B287","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cortex.2017.10.016","article-title":"How the human brain introspects about one's own episodes of cognitive control","volume":"107","author":"Soto","year":"2018","journal-title":"Cortex."},{"key":"B288","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41386-020-00906-2","article-title":"MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens","volume":"46","author":"M\u00fcller","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"B289","doi-asserted-by":"publisher","first-page":"16392","DOI":"10.1038\/s41598-020-73216-8","article-title":"The acute effects of the atypical dissociative hallucinogen salvinorin A on functional connectivity in the human brain","volume":"10","author":"Doss","year":"2020","journal-title":"Sci Rep."},{"key":"B290","doi-asserted-by":"publisher","first-page":"117653","DOI":"10.1016\/j.neuroimage.2020.117653","article-title":"alters dynamic integration and segregation in the human brain","volume":"227","author":"Luppi","year":"2021","journal-title":"Neuroimage."},{"key":"B291","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","article-title":"Increased global functional connectivity correlates with LSD-induced ego dissolution","volume":"26","author":"Tagliazucchi","year":"2016","journal-title":"Curr Biol."},{"key":"B292","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1038\/s41467-019-12658-9","article-title":"Consciousness-specific dynamic interactions of brain integration and functional diversity","volume":"10","author":"Luppi","year":"2019","journal-title":"Nat Commun."},{"key":"B293","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuroimage.2019.05.060","article-title":"Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin","volume":"199","author":"Lord","year":"2019","journal-title":"Neuroimage."},{"key":"B294","doi-asserted-by":"publisher","first-page":"117049","DOI":"10.1016\/j.neuroimage.2020.117049","article-title":"Serotonergic psychedelics LSD and psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains","volume":"220","author":"Varley","year":"2020","journal-title":"Neuroimage."},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211026454","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","author":"Mcculloch","year":"2021","journal-title":"J Psychopharmacol"},{"key":"B296","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41583-021-00428-w","article-title":"Cognitive and behavioural flexibility: neural mechanisms and clinical considerations","volume":"22","author":"Uddin","year":"2021","journal-title":"Nature Reviews Neuroscience."},{"key":"B297","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol Ther."},{"key":"B298","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hbm.21199","article-title":"Domain general and domain preferential brain regions associated with different types of task switching: a meta-analysis","volume":"33","author":"Kim","year":"2012","journal-title":"Hum Brain Mapp."},{"key":"B299","doi-asserted-by":"publisher","first-page":"e00225","DOI":"10.3389\/fphar.2015.00225","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Front Pharmacol"},{"key":"B300","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1007\/s00213-018-4981-x","article-title":"Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition","volume":"235","author":"Barrett","year":"2018","journal-title":"Psychopharmacology."},{"key":"B301","doi-asserted-by":"publisher","first-page":"niy008","DOI":"10.1093\/nc\/niy008","article-title":"Dimensions of consciousness and the psychedelic state","volume":"2018","author":"Bayne","year":"2018","journal-title":"Neurosci Consciousness."},{"key":"B302","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1101\/532234","article-title":"LSD acutely impairs working memory, executive functions, cognitive flexibility. but not risk-based decision-making","volume":"50","author":"Pokorny","year":"2019","journal-title":"Psychol Med"},{"key":"B303","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1162\/089892905774597191","article-title":"Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors","volume":"17","author":"Carter","year":"2005","journal-title":"J Cogn Neurosci."},{"key":"B304","article-title":"Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans","author":"Kanen","year":"2021","journal-title":"bioRxiv"},{"key":"B305","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00213-019-05445-3","article-title":"Ayahuasca's \u2018afterglow\u2019: improved mindfulness and cognitive flexibility in ayahuasca drinkers","volume":"237","author":"Murphy-Beiner","year":"2020","journal-title":"Psychopharmacology."},{"key":"B306","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuroscience.2016.06.005","article-title":"The neural underpinnings of cognitive flexibility and their disruption in psychotic illness","volume":"345","author":"Waltz","year":"2017","journal-title":"Neuroscience."},{"key":"B307","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00213-017-4610-0","article-title":"Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation","volume":"234","author":"Kraehenmann","year":"2017","journal-title":"Psychopharmacology (Berl)."},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-06006-3","article-title":"Low-dose LSD and the stream of thought: increased discontinuity of mind, deep thoughts and abstract flow","author":"Wie\u00dfner","year":"2021","journal-title":"Psychopharmacology"},{"key":"B309","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuroimage.2019.03.075","article-title":"Resting state functional connectivity and cognitive task-related activation of the human claustrum","volume":"196","author":"Krimmel","year":"2019","journal-title":"Neuroimage."},{"key":"B310","doi-asserted-by":"publisher","first-page":"116980","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","volume":"218","author":"Barrett","year":"2020","journal-title":"Neuroimage"},{"key":"B311","doi-asserted-by":"publisher","first-page":"e00064","DOI":"10.3389\/fnana.2019.00064","article-title":"A role for the claustrum in salience processing?","volume":"13","author":"Smith","year":"2019","journal-title":"Front Neuroanat"},{"key":"B312","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41398-018-0118-6","article-title":"Aberrant salience network functional connectivity in auditory verbal hallucinations: a first episode psychosis sample","volume":"8","author":"Mallikarjun","year":"2018","journal-title":"Transl Psychiatry."},{"key":"B313","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.euroneuro.2016.04.001","article-title":"Compulsivity\u2014a new trans-diagnostic research domain for the roadmap for mental health research in Europe (ROAMER) and research domain criteria (RDoC) initiatives","volume":"26","author":"Fineberg","year":"2016","journal-title":"Eur Neuropsychopharmacol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.euroneuro.2015.12.033","article-title":"The role of habit in compulsivity","volume":"26","author":"Gillan","year":"2016","journal-title":"Eur Neuropsychopharmacol."},{"key":"B315","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamapsychiatry.2019.2998","article-title":"Comparison of the association between goal-directed planning and self-reported compulsivity vs. obsessive-compulsive disorder diagnosis","volume":"77","author":"Gillan","year":"2019","journal-title":"JAMA Psychiatry."},{"key":"B316","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamapsychiatry.2018.0930","article-title":"Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review","volume":"75","author":"Dougherty","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"B317","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1271\/bbb.90095","article-title":"Effects of psilocybe argentipes on marble-burying behavior in mice","volume":"73","author":"Matsushima","year":"2009","journal-title":"Biosci Biotechnol Biochem"},{"key":"B318","doi-asserted-by":"publisher","first-page":"113093","DOI":"10.1016\/j.bbr.2020.113093","article-title":"Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI and citalopram on marble burying in mice","volume":"401","author":"Odland","year":"2021","journal-title":"Behav Brain Res."},{"key":"B319","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1503\/jpn.140249","article-title":"Elevated cognitive control over reward processing in recovered female patients with anorexia nervosa","volume":"40","author":"Ehrlich","year":"2015","journal-title":"J Psychiatry Neurosci."},{"key":"B320","doi-asserted-by":"publisher","first-page":"15074","DOI":"10.1038\/nrdp.2015.74","article-title":"Anorexia nervosa","volume":"1","author":"Treasure","year":"2015","journal-title":"Nat Rev Disease Primers."},{"key":"B321","doi-asserted-by":"publisher","first-page":"e00043","DOI":"10.3389\/fnins.2020.00043","article-title":"Rethinking therapeutic strategies for anorexia nervosa: insights from psychedelic medicine and animal models","volume":"14","author":"Foldi","year":"2020","journal-title":"Front Neurosci"},{"key":"B322","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fpsyt.2021.735523","article-title":"Study Protocol for \u201cPsilocybin as a Treatment for Anorexia Nervosa: A Pilot Study\u201d","author":"Spriggs","year":"2021"},{"key":"B323","doi-asserted-by":"publisher","first-page":"101973","DOI":"10.1016\/j.cpr.2021.101973","article-title":"Defining and measuring \u201cpsychological flexibility\u201d: a narrative scoping review of diverse flexibility and rigidity constructs and perspectives","volume":"84","author":"Cherry","year":"2021","journal-title":"Clin Psychol Rev."},{"key":"B324","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrn.2016.113","article-title":"Mind-wandering as spontaneous thought: a dynamic framework","volume":"17","author":"Christoff","year":"2016","journal-title":"Nat Rev Neurosci."},{"key":"B325","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J Context Behav Sci."},{"key":"B326","doi-asserted-by":"publisher","first-page":"116726","DOI":"10.1016\/j.neuroimage.2020.116726","article-title":"Updating the dynamic framework of thought: creativity and psychedelics","volume":"213","author":"Girn","year":"2020","journal-title":"Neuroimage."},{"key":"B327","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41398-021-01335-5","article-title":"Spontaneous and deliberate creative cognition during and after psilocybin exposure","volume":"11","author":"Mason","year":"2021","journal-title":"Transl Psychiatry."},{"key":"B328","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/0269881107077734","article-title":"Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and NN-dimethyltryptamine (DMT) models of psychosis","volume":"21","author":"Heekeren","year":"2007","journal-title":"J Psychopharmacol."},{"key":"B329","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00213-008-1237-1","article-title":"Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis","volume":"200","author":"Daumann","year":"2008","journal-title":"Psychopharmacology (Berl)."},{"key":"B330","doi-asserted-by":"publisher","first-page":"103070","DOI":"10.1016\/j.concog.2020.103070","article-title":"The entropic tongue: disorganization of natural language under LSConsciousness D","volume":"87","author":"Sanz","year":"2021","journal-title":"Cognition"},{"key":"B331","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/wps.20491","article-title":"Prediction of psychosis across protocols and risk cohorts using automated language analysis","volume":"17","author":"Corcoran","year":"2018","journal-title":"World Psychiatry."},{"key":"B332","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/lio2.354","article-title":"Automated assessment of psychiatric disorders using speech: a systematic review","volume":"5","author":"Low","year":"2020","journal-title":"Laryngosc Investig Otolaryngol."},{"key":"B333","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41537-019-0085-9","article-title":"Detecting relapse in youth with psychotic disorders utilizing patient-generated and patient-contributed digital data from Facebook npj","volume":"5","author":"Birnbaum","year":"2019","journal-title":"Schizophrenia."},{"key":"B334","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00213-017-4769-4","article-title":"Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences","volume":"235","author":"Carbonaro","year":"2018","journal-title":"Psychopharmacology (Berl)."},{"key":"B335","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/7854_2016_461","article-title":"Serotonergic Hallucinogen-Induced Visual Perceptual Alterations","volume":"36","author":"Kometer","year":"2018","journal-title":"Curr Top Behav Neurosci."},{"key":"B336","doi-asserted-by":"publisher","first-page":"niaa024","DOI":"10.1093\/nc\/niaa024","article-title":"Neural network models for DMT-induced visual hallucinations","volume":"2020","author":"Schartner","year":"2020","journal-title":"Neurosci Conscious"},{"key":"B337","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0269881106065859","article-title":"Effects of psilocybin on time perception and temporal control of behaviour in humans","volume":"21","author":"Wittmann","year":"2007","journal-title":"J Psychopharmacol."},{"key":"B338","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","article-title":"The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial","volume":"236","author":"Yanakieva","year":"2019","journal-title":"Psychopharmacology."},{"key":"B339","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.concog.2012.03.009","article-title":"Genuine and drug-induced synesthesia: a comparison","volume":"21","author":"Sinke","year":"2012","journal-title":"Conscious Cogn."},{"key":"B340","doi-asserted-by":"publisher","first-page":"e00753","DOI":"10.3389\/fpsyg.2013.00753","article-title":"The induction of synaesthesia with chemical agents: a systematic review","volume":"4","author":"Luke","year":"2013","journal-title":"Front Psychol"},{"key":"B341","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/schbul\/sbaa117","article-title":"Hallucinations under psychedelics and in the schizophrenia spectrum: an interdisciplinary and multiscale comparison","volume":"46","author":"Leptourgos","year":"2020","journal-title":"Schizophr Bull."},{"key":"B342","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10194-019-0958-3","article-title":"Abnormal functional connectivity under somatosensory stimulation in migraine: a multi-frequency magnetoencephalography study","volume":"20","author":"Ren","year":"2019","journal-title":"J Headache Pain."},{"key":"B343","doi-asserted-by":"publisher","first-page":"16324","DOI":"10.1038\/s41598-019-51974-4","article-title":"Neural correlates of the DMT experience assessed with multivariate EEG","volume":"9","author":"Timmermann","year":"2019","journal-title":"Sci Rep."},{"key":"B344","doi-asserted-by":"publisher","first-page":"e59784","DOI":"10.7554\/eLife.59784.sa2","article-title":"DMT alters cortical travelling waves","volume":"9","author":"Alamia","year":"2020","journal-title":"Elife."},{"key":"B345","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41398-021-01603-4","article-title":"Psilocin, LSD mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity","volume":"11","author":"Vejmola","year":"2021","journal-title":"Transl Psychiatry."},{"key":"B346","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fpsyt.2017.00240","article-title":"The \u201cEndless Trip\u201d among the NPS Users: psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. A systematic review","volume":"8","author":"Orsolini","year":"2017","journal-title":"Front Psychiatry."},{"key":"B347","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/7854_2016_457","article-title":"A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD","volume":"36","author":"Halpern","year":"2018","journal-title":"Curr Top Behav Neurosci."},{"key":"B348","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/brainsci8030047","article-title":"Hallucinogen persisting perception disorder: etiology, clinical features, therapeutic perspectives","volume":"8","author":"Martinotti","year":"2018","journal-title":"Brain Sci"},{"key":"B349","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/brain\/aws129","article-title":"A Bayesian account of \u2018hysteria\u2019","volume":"135","author":"Edwards","year":"2012","journal-title":"Brain."},{"key":"B350","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12888-016-0890-x","article-title":"Neural correlates of conversion disorder: overview and meta-analysis of neuroimaging studies on motor conversion disorder","volume":"16","author":"Boeckle","year":"2016","journal-title":"BMC Psychiatry."},{"key":"B351","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jnnp-2018-319201","article-title":"Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda","volume":"90","author":"Pick","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B352","doi-asserted-by":"publisher","first-page":"2045125320912125","DOI":"10.1177\/2045125320912125","article-title":"Psychedelic treatment of functional neurological disorder: a systematic review","volume":"10","author":"Butler","year":"2020","journal-title":"Therap Adv Psychopharmacol"},{"key":"B353","doi-asserted-by":"publisher","first-page":"e00688","DOI":"10.1002\/prp2.688","article-title":"Psychedelic-assisted therapy for functional neurological disorders: a theoretical framework and review of prior reports","volume":"8","author":"Stewart","year":"2020","journal-title":"Pharmacol Res Perspect."},{"key":"B354","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.biopsych.2021.02.036","article-title":"Altered prediction-error processing may underlie psilocybin-induced changes in self-processing","volume":"89","author":"Preller","year":"2021","journal-title":"Biol Psychiatry."},{"key":"B355","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1017\/ipm.2017.7","article-title":"Dimensional thinking in psychiatry in the era of the research domain criteria (RDoC)","volume":"35","author":"Kelly","year":"2018","journal-title":"Ir J Psychol Med."},{"key":"B356","doi-asserted-by":"publisher","first-page":"e21573","DOI":"10.1001\/jamapsychiatry.2021.2573","article-title":"Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis","author":"Nikolova","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B357","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fncel.2015.00392","article-title":"Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders","volume":"9","author":"Kelly","year":"2015","journal-title":"Front Cell Neurosci."},{"key":"B358","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev."},{"key":"B359","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpsychires.2016.07.019","article-title":"Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat","volume":"82","author":"Kelly","year":"2016","journal-title":"J Psychiatr Res"},{"key":"B360","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat Neurosci."},{"key":"B361","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","article-title":"Serotonin, tryptophan metabolism and the brain-gut-microbiome axis","volume":"277","author":"O'mahony","year":"2015","journal-title":"Behav Brain Res"},{"key":"B362","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1113\/jphysiol.2004.063388","article-title":"Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice","volume":"558","author":"Sudo","year":"2004","journal-title":"J Physiol."},{"key":"B363","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","article-title":"Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve","volume":"108","author":"Bravo","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B364","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","article-title":"The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?","volume":"99","author":"Stilling","year":"2016","journal-title":"Neurochem Int."},{"key":"B365","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.biopsych.2018.06.014","article-title":"Programming bugs: microbiota and the developmental origins of brain health and disease","volume":"85","author":"Codagnone","year":"2019","journal-title":"Biol Psychiatry."},{"key":"B366","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.schres.2020.02.010","article-title":"The role of the gut microbiome in the development of schizophrenia","volume":"234","author":"Kelly","year":"2020","journal-title":"Schizophr Res"},{"key":"B367","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.1010529108","article-title":"Normal gut microbiota modulates brain development and behavior","volume":"108","author":"Diaz Heijtz","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B368","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci Transl Med"},{"key":"B369","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.biopsych.2014.12.023","article-title":"O'leary OF. Adult hippocampal neurogenesis is regulated by the microbiome","volume":"78","author":"Ogbonnaya","year":"2015","journal-title":"Biol Psychiatry."},{"key":"B370","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1038\/tp.2016.42","article-title":"Regulation of prefrontal cortex myelination by the microbiota","volume":"6","author":"Hoban","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B371","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1111\/ejn.13291","article-title":"Adult microbiota-deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus","volume":"44","author":"Luczynski","year":"2016","journal-title":"Eur J Neurosci."},{"key":"B372","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/mp.2013.65","article-title":"Microbiota is essential for social development in the mouse","volume":"19","author":"Desbonnet","year":"2014","journal-title":"Mol Psychiatry."},{"key":"B373","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbi.2015.04.004","article-title":"Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour","volume":"48","author":"Desbonnet","year":"2015","journal-title":"Brain Behav Immun."},{"key":"B374","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1124\/pr.118.015768","article-title":"Gut reactions: breaking down xenobiotic-microbiome interactions","volume":"71","author":"Clarke","year":"2019","journal-title":"Pharmacol Rev."},{"key":"B375","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature."},{"key":"B376","doi-asserted-by":"publisher","first-page":"103307","DOI":"10.1016\/j.ebiom.2021.103307","article-title":"The gut microbiome influences the bioavailability of olanzapine in rats","volume":"66","author":"Cussotto","year":"2021","journal-title":"EBioMedicine."},{"key":"B377","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2015.02.021","article-title":"Collective unconscious: how gut microbes shape human behavior","volume":"63","author":"Dinan","year":"2015","journal-title":"J Psychiatr Res."},{"key":"B378","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mehy.2019.02.029","article-title":"Psychedelic medicine: the biology underlying the persisting psychedelic effects","volume":"125","author":"Kuypers","year":"2019","journal-title":"Med Hypotheses."},{"key":"B379","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/IJPSYM.IJPSYM_492_19","article-title":"Psychiatry's future: biology, psychology, legislation, and \u201cthe fierce urgency of now\u201d","volume":"42","author":"Kelly","year":"2020","journal-title":"Indian J Psychol Med."},{"key":"B380","unstructured":"InselTR\n          Star Neuroscientist Tom Insel Leaves the Google-Spawned Verily for a Startup.2017"},{"key":"B381","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/psyp.12612","article-title":"RDoC: translating promise into progress","volume":"53","author":"Patrick","year":"2016","journal-title":"Psychophysiology."},{"key":"B382","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/wps.20631","article-title":"Transdiagnostic psychiatry: a systematic review","volume":"18","author":"Fusar-Poli","year":"2019","journal-title":"World Psychiatry."},{"key":"B383","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000493685","article-title":"Research domain criteria: cutting edge neuroscience or galen's humors revisited?","volume":"4","author":"Ross","year":"2018","journal-title":"Complex Psychiatry."},{"key":"B384","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000501797","article-title":"Research domain criteria: strengths, weaknesses, and potential alternatives for future psychiatric research","volume":"5","author":"Ross","year":"2019","journal-title":"Complex Psychiatry."},{"key":"B385","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/wps.20800","article-title":"RDoC at 10: changing the discourse for psychopathology","volume":"19","author":"Sanislow","year":"2020","journal-title":"World Psychiatry."},{"key":"B386","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0269881121991822","article-title":"Optimal dosing for psilocybin pharmacotherapy: considering weight-adjusted and fixed dosing approaches","volume":"35","author":"Garcia-Romeu","year":"2021","journal-title":"J Psychopharmacol."},{"key":"B387","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/a-1524-2794","article-title":"Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports","volume":"54","author":"Nayak","year":"2021","journal-title":"PsyArXiv"},{"key":"B388","doi-asserted-by":"publisher","first-page":"e586682","DOI":"10.3389\/fpsyt.2021.586682","article-title":"Development and evaluation of a therapist training program for psilocybin therapy for treatment-resistant depression in clinical research","volume":"12","author":"Tai","year":"2021","journal-title":"Front Psychiatry"},{"key":"B389","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.euroneuro.2015.08.019","article-title":"A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature","volume":"25","author":"Zohar","year":"2015","journal-title":"Eur Neuropsychopharmacol."},{"key":"B390","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cell.2014.02.012","article-title":"Individualized medicine from prewomb to tomb","volume":"157","author":"Topol","year":"2014","journal-title":"Cell."},{"key":"B391","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fpsyt.2019.00505","article-title":"A literature overview of virtual reality (VR) in treatment of psychiatric disorders: recent advances and limitations","volume":"10","author":"Park","year":"2019","journal-title":"Front Psychiatry."},{"key":"B392","doi-asserted-by":"publisher","first-page":"2045125320948356","DOI":"10.1177\/2045125320948356","article-title":"Psychedelics and virtual reality: parallels and applications","volume":"10","author":"Aday","year":"2020","journal-title":"Therap Adv Psychopharmacol."},{"key":"B393","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-neuro-101220-014053","article-title":"Smartphones and the neuroscience of mental health","volume":"44","author":"Gillan","year":"2021","journal-title":"Annu Rev Neurosci"},{"key":"B394","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211008567","article-title":"Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?","author":"Carhart-Harris","year":"2021","journal-title":"J Psychopharmacol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.800072\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T08:57:04Z","timestamp":1639731424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.800072\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":394,"alternative-id":["10.3389\/fpsyt.2021.800072"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.800072","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"article-number":"800072"}}